US - HealthQuill

A ten-fold increase in measles cases was reported from Europe last year, while the numbers shot up 11-fold this year until April 18, in the American region, according to two global health agencies.

In Europe measles up 10-fold last year, Americas region up by 11-fold in 2025

HQ Team April 29, 2025: A ten-fold increase in measles cases was reported from Europe last year, while the numbers shot up 11-fold.

by HealthQuill
April 29, 2025
0 Comments

Drugs Medical Pharma

Roche to invest $50 billion in US over next five years to expand capacity

HQ Team April 22, 2025: Swiss healthcare multinational F. Hoffmann-La Roche AG will invest $50 billion in the US over the next five.

by HealthQuill
April 22, 2025
0 Comments

Generic drugs made in India, which account for 93% of such medicines made from emerging countries, are linked to hospitalisation, disability and in a few cases death, compared to the US, according to a study by the Ohio State University.

Drugs Health Research

Generic Indian drugs have a 54% higher risk compared to US

HQ Team April 18, 2025: Generic drugs made in India, which account for 93% of such medicines made from emerging countries, are linked.

by HealthQuill
April 18, 2025
0 Comments

Pfizer Inc. stopped its trial of danuglipron for treating chronic weight management after an asymptomatic patient developed a drug-induced liver injury that was resolved after discontinuation of the oral drug.

Uncategorized

Pfizer stops development of an investigational drug to treat obesity

HQ Team April 15, 2025: Pfizer Inc. stopped its trial of danuglipron for treating chronic weight management after an asymptomatic patient developed a.

by HealthQuill
April 15, 2025
0 Comments

Bristol Myers Squibb’s end-phase trial to test a drug for treating a heart condition, where the muscle of the heart's main pumping chamber becomes abnormally thickened, has failed to meet its goals.

Drugs Health Medical

Bristol Myers’ test drug to treat a type of heart disease fails to meet goals

HQ Team April 15, 2025: Bristol Myers Squibb’s end-phase trial to test a drug for treating a heart condition, where the muscle of.

by HealthQuill
April 15, 2025
0 Comments

AstraZeneca’s combination drug for the treatment of adults with resectable non-small cell lung cancer has got approval from the European Union.

Drugs Health Pharma

AstraZeneca’s lung cancer drug combination gets EU approval

HQ Team April 4, 2025: AstraZeneca’s combination drug for the treatment of adults with resectable non-small cell lung cancer has got approval from.

by HealthQuill
April 4, 2025
0 Comments

Amgen Inc.’s treatment for adults living with immune-mediated inflammatory conditions was granted regulatory approval by the US Food and Drug Administration, according to a statement.

Drugs Health Medical

Amgen gets US approval to treat immunoglobulin G4-related disease

HQ Team April 4, 2025: Amgen Inc.’s treatment for adults living with immune-mediated inflammatory conditions was granted regulatory approval by the US Food and.

by HealthQuill
April 4, 2025
0 Comments

The US Food and Drug Administration has rejected the biotechnology company Aldeyra Therapeutics Inc’s investigational drug for treating dry eyes, over concerns with the data from the trial.

Drugs Health Medical

Aldeyra Therapeutics’ dry eye treatment rejected by USFDA

HQ Team April 3, 2025: The US Food and Drug Administration has rejected the biotechnology company Aldeyra Therapeutics Inc’s investigational drug for treating.